Pegfilgrastim biosimilar (Amega Biotech)

培非格司亭生物类似药 (Amega Biotech)

Report date: 2022/01/21 13:30:17

Base Information

Drug NamePegfilgrastim biosimilar (Amega Biotech)

Drug Alias NamePeg-filgrastim biosimilar (Amega Biotech)培非司亭生物仿制药 (Amega Biotech)Recombinant pegfilgrastim (Amega Biotech)聚乙二醇化非格司亭生物仿制药 (Amega Biotech)聚乙二醇化重组人粒细胞刺激因子生物仿制药 (Amega Biotech)

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar

Mechanisms of ActionColony stimulating factor 3 receptor agonists

TargetsColony stimulating factor 3 receptor

Therapy Area/IndicationsNeutropenia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesAmega Biotech

China Registration ClassN/A

Develop Information

Active CompaniesAmega Biotech

Inactive CompaniesN/A

Active IndicationsNeutropenia

Inactive IndicationsN/A

Other Information

ATC CodeL03AA13